D. Brockmeier

1.5k total citations
44 papers, 1.2k citations indexed

About

D. Brockmeier is a scholar working on Pharmaceutical Science, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, D. Brockmeier has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in D. Brockmeier's work include Drug Solubulity and Delivery Systems (10 papers), Analytical Chemistry and Chromatography (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). D. Brockmeier is often cited by papers focused on Drug Solubulity and Delivery Systems (10 papers), Analytical Chemistry and Chromatography (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). D. Brockmeier collaborates with scholars based in Germany, Czechia and Austria. D. Brockmeier's co-authors include Michel Eichelbaum, Dieter Schrenk, Karl Walter Bock, Dorothee Wernet, Christine Fischer, Klaus Moerike, Ulrich M. Zanger, Matthias Schwab, Elke Schaeffeler and Ernst‐Ulrich Griese and has published in prestigious journals such as Biochemical Journal, The FASEB Journal and Pain.

In The Last Decade

D. Brockmeier

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Brockmeier Germany 15 325 268 261 207 181 44 1.2k
Donald Jung United States 22 518 1.6× 179 0.7× 218 0.8× 228 1.1× 333 1.8× 67 2.3k
Bo Odlind Sweden 21 287 0.9× 71 0.3× 148 0.6× 173 0.8× 178 1.0× 56 1.4k
Klaus Kutz Switzerland 21 297 0.9× 98 0.4× 141 0.5× 434 2.1× 304 1.7× 59 1.8k
Elaine Radwanski United States 21 211 0.6× 86 0.3× 160 0.6× 304 1.5× 263 1.5× 62 1.8k
B.K. Park United Kingdom 20 239 0.7× 152 0.6× 557 2.1× 131 0.6× 213 1.2× 57 1.3k
Joachim Grevel United States 24 347 1.1× 146 0.5× 150 0.6× 704 3.4× 266 1.5× 64 2.2k
Gérard Fabre France 21 391 1.2× 121 0.5× 436 1.7× 129 0.6× 404 2.2× 58 1.4k
Don K. Walker United Kingdom 22 631 1.9× 87 0.3× 385 1.5× 176 0.9× 309 1.7× 40 2.2k
Henri Frischer United States 22 411 1.3× 478 1.8× 162 0.6× 239 1.2× 120 0.7× 57 1.7k
HJ Rogers United Kingdom 21 262 0.8× 98 0.4× 138 0.5× 80 0.4× 153 0.8× 38 948

Countries citing papers authored by D. Brockmeier

Since Specialization
Citations

This map shows the geographic impact of D. Brockmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Brockmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Brockmeier more than expected).

Fields of papers citing papers by D. Brockmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Brockmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Brockmeier. The network helps show where D. Brockmeier may publish in the future.

Co-authorship network of co-authors of D. Brockmeier

This figure shows the co-authorship network connecting the top 25 collaborators of D. Brockmeier. A scholar is included among the top collaborators of D. Brockmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Brockmeier. D. Brockmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaeffeler, Elke, Christine Fischer, D. Brockmeier, et al.. (2004). Comprehensive analysis of thiopurine S-methyltransferase phenotype–genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics. 14(7). 407–417. 325 indexed citations
2.
Repp, Holger, Andreas Koschinski, Eugen Domann, et al.. (2002). Listeriolysin of Listeria monocytogenes forms Ca2+-permeable pores leading to intracellular Ca2+ oscillations. Cellular Microbiology. 4(8). 483–491. 87 indexed citations
3.
Brockmeier, D., et al.. (2001). Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. Urology. 58(4). 589–593. 16 indexed citations
4.
Schrenk, Dieter, D. Brockmeier, Klaus Mörike, Karl Walter Bock, & Michel Eichelbaum. (1998). A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. European Journal of Clinical Pharmacology. 53(5). 361–367. 94 indexed citations
5.
Brockmeier, D.. (1998). Tight binding influencing the future of pharmacokinetics. Methods and Findings in Experimental and Clinical Pharmacology. 20(6). 505–505. 1 indexed citations
6.
Brockmeier, D.. (1995). Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurements.. PubMed. 33(12). 631–8. 4 indexed citations
7.
8.
Reichel, Christoph, M von Falkenhausen, D. Brockmeier, & H. J. Dengler. (1994). Characterization of cyclosporine a uptake in human erythrocytes. European Journal of Clinical Pharmacology. 46(5). 417–419. 18 indexed citations
9.
Liebenhoff, U, D. Brockmeier, & Peter Presek. (1993). Substrate affinity of the protein tyrosine kinase pp60c-src is increased on thrombin stimulation of human platelets. Biochemical Journal. 295(1). 41–48. 28 indexed citations
10.
Heintz, Bernhard, M. Verho, D. Brockmeier, et al.. (1993). Multiple-Dose Pharmacokinetics of Ramipril in Patients with Chronic Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 22. S36–S36. 9 indexed citations
11.
Rietbrock, Stephan, Brigitte Keller‐Stanislawski, Petra Thürmann, & D. Brockmeier. (1992). Pharmacokinetic profile of a novel slow release preparation of molsidomine. European Journal of Clinical Pharmacology. 43(3). 273–276. 6 indexed citations
12.
Brockmeier, D., et al.. (1992). Pharmacokinetic profile of cefodizime. Infection. 20(S1). S14–S17. 12 indexed citations
13.
Heintz, Bernhard, M. Verho, D. Brockmeier, et al.. (1991). Influence of Ramipril on Renal Function in Patients with Chronic Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 18. S174–S179. 2 indexed citations
14.
Brünner, Friedrich, et al.. (1990). Evidence for muscarinic receptors in endothelial cells from combined functional and binding studies. European Journal of Pharmacology. 187(2). 145–154. 10 indexed citations
15.
Brockmeier, D., Wolfgang Henke, E. Mutschler, et al.. (1988). Penbutolol: Pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding. European Journal of Clinical Pharmacology. 35(6). 613–623. 3 indexed citations
16.
Lameire, Norbert, et al.. (1988). Pharmakokinetik von Roxatidinacetat bei chronischer Niereninsuffizienz. Drugs. 35(Supplement 3). 48–52. 14 indexed citations
17.
Lameire, Norbert, Bernd Rosenkranz, & D. Brockmeier. (1988). Pharmacokinetics of Histamine (H2)-Receptor Antagonists, including Roxatidine, in Chronic Renal Failure. Scandinavian Journal of Gastroenterology. 23(sup146). 100–110. 10 indexed citations
18.
Brockmeier, D., H.-G. Grigoleit, & H Leonhardt. (1986). The absorption of piretanide from the gastro-intestinal tract is site-dependent. European Journal of Clinical Pharmacology. 30(1). 79–82. 27 indexed citations
19.
Brockmeier, D., et al.. (1986). In vitro-in vivo correlation of dissolution using moments of dissolution and transit times. Universitätsbibliothek Gießen. 17 indexed citations
20.
Brockmeier, D.. (1984). In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times.. PubMed. 34(11). 1604–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald Jung Breakdown of academic impact, for papers by Bo Odlind Breakdown of academic impact, for papers by Klaus Kutz Breakdown of academic impact, for papers by Elaine Radwanski Breakdown of academic impact, for papers by B.K. Park Breakdown of academic impact, for papers by Joachim Grevel Breakdown of academic impact, for papers by Gérard Fabre Breakdown of academic impact, for papers by Don K. Walker Breakdown of academic impact, for papers by Henri Frischer Breakdown of academic impact, for papers by HJ Rogers
Rankless by CCL
2026